Intravascular stenting of acute experimental type B dissections.

Department of Cardiovascular and Thoracic Surgery, Stanford University School of Medicine, California 94305.
Journal of Surgical Research (Impact Factor: 2.12). 05/1993; 54(4):381-8. DOI: 10.1006/jsre.1993.1061
Source: PubMed

ABSTRACT To evaluate the efficacy of intravascular stenting for acute aortic dissection, 12 dogs underwent surgical creation of an acute type B dissection. Intravascular ultrasound evaluated luminal diameter, distal propagation, and branch involvement. Three animals underwent no further treatment (control). In 9 dogs, balloon-expandable intravascular stents (15-20 mm) were placed proximally to compress the intimal flap. One dog with a small dissection had complete obliteration of the false lumen after initial stent placement. Six dogs with extension below the diaphragm were initially stented proximally to restore flow; 3 were left with a residual distal false lumen, while 3 had additional stents placed to obliterate their entire false lumen. In the final 2 dogs, proximal stenting resulted only in partial compression of the false lumen. Two animals died within 24 hr due to prolonged hemodynamic instability and aortic rupture at the intimal flap, respectively. Six weeks later, radiologic and histologic evaluation was performed on the 10 surviving animals. All stented true lumens were patent without thrombus formation, and stents were covered by neointima. In dogs with stenting of the entire dissection, the aortic wall had healed and no false lumen was present. However, in all dogs with only proximal obliteration, 1/2 with partial compression, and 2/3 controls, a patent false channel was present indicative of a chronic dissection. Thus, we found that intravascular stents can restore true lumen flow and obliterate the false lumen in experimental dissections; however, stenting limited to the proximal dissection does not prevent formation of a chronic residual patent false lumen.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Aortic dissection is a complex manifestation of disease of the arterial wall. The severity and consequences of a dissection are related to the physical characteristics and anatomic location of the tear as well as the underlying patient physiology. Despite in vitro and in vivo modeling advances, our understanding of the pathophysiology has been limited to evaluations of the success and failure of various treatment modalities. The indications for intervention have historically included rupture, intractable pain or hypertension, distal ischemia and degeneration of the aortic wall causing aneurysm formation.The management decisions for patients with dissections are dependent upon the abnormal anatomy, the acuity of the patient presentation, and physiology. Despite the availability of open surgery as a therapeutic option, acute dissections with evidence of ischemia are now handled using an endovascular approach that is specifically directed at the cause of the ischemia. Endovascular treatments include the placement of a stentgraft into the proximal aorta, branch vessel stenting, uncovered stent placement in the abdominal aorta, and aortic fenestrations. Chronic dissections, in contrast, are still most frequently managed with open surgical techniques. However, a subset of patients that are not candidates for traditional surgical repair of the thoracoabdominal aorta may be managed with a combined open mesenteric revascularization with subsequent endovascular grafting of the thoracoabdominal aorta.
    European Journal of Vascular and Endovascular Surgery 12/2003; 26(6):579-586. DOI:10.1016/S1078-5884(03)00415-5 · 3.07 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: TEVAR is a new strategy for treating both acute and chronic type B aortic dissection. The JSC guidelines classify TEVAR as a Class I recommendation for cases of complicated acute type B dissection and a Class IIa recommendation for cases of chronic type B aortic dissection. While TEVAR has been primarily applied to treat complicated acute type B aortic dissection in Europe and the USA, the procedure remains an off-label treatment strategy for aortic dissection in Japan. The current state of TEVAR for type B aortic dissection in Japan from 2001 to 2011 is estimated in the annual reports of the Japanese Association for Thoracic Surgery. The number of acute type B aortic dissection patients treated with transluminal stent grafting increased rapidly after 2008, from 10 cases in 2001 to 76 cases in 2010. Meanwhile, the number acute type B aortic dissection patients treated with any type of surgery has increased gradually, from 100 cases in 2001 to 194 cases in 2009. The number of chronic type B aortic dissection patients treated with transluminal stent grafting increased abruptly in 2010, reaching 346 cases, which accounted for one-third of all surgical procedures for chronic type B aortic dissection. Furthermore, the number of open surgeries for chronic type B aortic dissection has also increased gradually, from 401 cases in 2001 to 947 cases in 2011. At present, open surgery, TEVAR and hybrid procedures are available to treat patients with type B aortic dissection. The use of a multidisciplinary team approach is mandatory when selecting the appropriate surgical strategy.
    General Thoracic and Cardiovascular Surgery 12/2013; DOI:10.1007/s11748-013-0348-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Die Entwicklung und der Einsatz endoluminaler Aortenprothesen haben insbesondere im Akutstadium mit Ruptur oder Endorganischämie das Therapiespektrum von Stanford-B-Dissektionen erweitert. Die bisherige alleinige offen-chirurgische Therapie ist die Aorten- Fensterungsoperation oder der primäre prothetische Aortenersatz zum Entry-Verschluss. Moderne bildgebende Schnittbildverfahren (CT oder MRT) mit 3D-Rekonstruktionen ermöglichen eine exakte präoperative Diagnostik und Planung einer chirurgischen Therapie, entweder offen oder endovaskulär. Die Therapieziele der endovaskulären Rekonstruktion ist der endoluminale Verschluss des proximalen Entrys, die darauffolgende Entfaltung des komprimierten wahren Lumens und die Induktion einer Thrombosierung des thorakalen Falschkanals. Dadurch soll eine Expansion des Falschkanals im Langzeitverlauf mit der Gefahr einer späteren Ruptur vermieden werden. Die endovaskuläre Implantationstechnik ist bei akuten und chronisch-expandierenden Aortendissektionen sehr anspruchsvoll und mit potentiellen Komplikationen behaftet. Das Konzept des endoluminalen Entry-Verschlusses bei akuter symptomatischer B-Dissektion ist dennoch vielversprechend und stellt eine Therapiealternative dar. Langzeitergebnisse der endovaskulären Therapie liegen bisher nicht vor. Die erforderlichen prospektiv-vergleichenden Studien werden zukünftig Klarheit bringen, sind aber durch die komplexe Morphologie und heterogene Population erschwert. Die Entwicklung einer speziellen Endoprothese zur Behandlung der akuten und chronischen Aortendissektion ist notwendig.
    Gefässchirurgie 08/2005; 10(4):293-313. DOI:10.1007/s00772-005-0400-9 · 0.24 Impact Factor